CIK 0000730272 · Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042729386
- Phone
- 7814499560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure · Other events
- 8-K Event Material agreement · Other events
- 8-K Event Results of operations
- 8-K/A Event Other events
- 8-K Event Executive or director change
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- 8-K Event Material agreement · Other events
- 8-K/A Event Other events
- 8-K Event Material agreement · Results of operations · Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Results of operations
Page 5 of 16 · 318 filings